Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions

Masanari Itokawa, Zhicheng Lin, Ning-Sheng Cai, Cindy Wu, Shigeo Kitayama, Jia-Bei Wang and George R. Uhl
Molecular Pharmacology June 2000, 57 (6) 1093-1103;
Masanari Itokawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhicheng Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ning-Sheng Cai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cindy Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeo Kitayama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jia-Bei Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George R. Uhl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Polar residues in dopamine transporter (DAT) transmembrane domains (TMs) are likely to act individually and even interactively in recognizing cocaine and dopamine. We initially evaluated the effects of alanine substitution mutants that remove the polar side chains from residues in each of the 12 putative DAT TMs on the recognition of dopamine and the cocaine analog CFT. Eleven combination mutants with multiple substitutions in DAT TMs 4, 5, 7, or 11 were then selected as candidates for more detailed evaluation based on mutation effects on dopamine and cocaine analog affinities. An evaluation of Gibbs free energy changes displayed by single and combined TM mutants (ΔGo and ΔΔGoint) reveals three categories of potential interactions among mutants: 1) independent, noncooperative interactions (five influenced CFT and two influenced dopamine affinities), 2) synergistic influences (two for CFT and four for dopamine), and 3) complementation of influences on CFT recognition (four mutants) or on dopamine affinity (five). Combined mutations in TMs 4 and 5 yield the largest ΔΔGoint values for dopamine uptake. TMs 4 and 11 mutants provide the largest ΔΔGoint for CFT binding. Interactions between residues lying in DAT TMs 4 and 5 support current DAT structural models that suggest the juxtaposition of these two TMs. These data also support contributions of TM 4 and 11 residues to a polar pocket important for cocaine recognition. These candidate interactive DAT polar domains provide larger target sites for compounds that could modulate specific DAT functions than those provided by single mutations alone.

Footnotes

  • Send reprint requests to: Dr. George R. Uhl, Molecular Neurobiology, P. O. Box 5180, National Institute on Drug Abuse, National Institutes of Health, 5500 Nathan Shock Drive, Baltimore, MD 21224. E-mail: guhl{at}intra.nida.nih.gov

  • ↵1 Cellular Neurobiology Branch, NIDA, Intramural Research Program, National Institutes of Health, Bethesda, MD 21224.

  • ↵2 Department of Pharmacology, Hiroshima University/School of Dentistry, Hiroshima 734-8553, Japan.

  • ↵3 Department of Pharmaceutical Science, University of Maryland, Baltimore, MD 21201.

  • This work was supported by National Institute on Drug Abuse, National Institutes of Health, Intramural Research Program.

  • Abbreviations:
    DAT
    dopamine transporter
    CFT
    (−)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane
    rDAT
    rat dopamine transporter
    TM
    transmembrane domain
    WT
    wild type
    • Received October 6, 1999.
    • Accepted February 9, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (6)
Molecular Pharmacology
Vol. 57, Issue 6
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions

Masanari Itokawa, Zhicheng Lin, Ning-Sheng Cai, Cindy Wu, Shigeo Kitayama, Jia-Bei Wang and George R. Uhl
Molecular Pharmacology June 1, 2000, 57 (6) 1093-1103;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions

Masanari Itokawa, Zhicheng Lin, Ning-Sheng Cai, Cindy Wu, Shigeo Kitayama, Jia-Bei Wang and George R. Uhl
Molecular Pharmacology June 1, 2000, 57 (6) 1093-1103;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
  • EIPA, HMA and SMN2 gene regulation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics